Insights On Outsourced Drug Development
-
AI-Enabled Phenotypic Analysis Of Label-Free Intestinal Organoids
3/10/2025
Discover how advanced 3D models and AI-enabled imaging techniques revolutionize organoid research, which provides accurate phenotypic analysis to monitor growth and development in various organoid types.
-
Reach Development Goals Faster With Multi-Sample Workflow Technology
5/4/2024
Explore the use of Differential Scanning Calorimetry (DSC) multi-sample technology to analyze a variety of pharmaceutical materials and understand critical information for advancing pharma development.
-
Revolutionizing Drug Discovery From "Undruggables" To AI
6/10/2024
Explore four current trends in drug discovery, how each trend addresses some of the most crucial challenges in drug discovery, and the obstacles to their widespread adoption.
-
Step-By-Step Guide To Tech Transfer Preparation And Execution
10/31/2024
How does a sponsor accurately transfer detailed knowledge about its product composition, development, and current manufacturing processes to its CDMO?
-
Risk Management Processes For Cell And Gene Therapies
7/9/2024
Delve into several considerations of risk and knowledge management in the cell and gene therapy environment, providing essential insights for effective product development.
-
Transforming A Liquid Protein Solution Into A Solid Oral Dosage Form
3/4/2025
Unlocking the potential of oral protein therapeutics requires innovative formulation and manufacturing strategies to overcome stability, absorption, and bioavailability challenges.
-
Inside The Development Of An AAV8 Production Platform
4/24/2025
Explore innovative solutions for AAV8 production challenges, which include scalability and purity, as well as learn how a collaboration with CDMO Matica Biotechnology ensures efficient, high-yield gene therapy vector production.
-
White Paper: Nasal Delivery Of Spray Dried Biologics: Opportunities And Challenges
10/16/2024
Explore the potential of spray-dried nasal formulations for biologics to achieve excellent stability and targeted delivery, paving the way for innovative and effective therapeutic solutions.
-
Next Generation Conjugates: Process And Analytical Challenges
3/25/2024
Explore specific examples of challenges commonly encountered in the process and analytical development of next-generation conjugates as well as corresponding solutions for each.
-
Monolithic Columns As Downstream Processing Solutions For Lentiviral Purification
11/27/2024
Third-generation lentiviral vectors enable efficient gene delivery, but purification challenges limit in vivo applications. Monolithic columns and advanced assays show promise for downstream processes.